{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:44:22Z","timestamp":1778867062922,"version":"3.51.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Chemours Company FC, LLC"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Like many per- and polyfluoroalkyl substances (PFAS), toxicity studies for short-chain HFPO-DA (ammonium, 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate) indicate the liver is the primary target of toxicity in rodents. However, neonatal mortality and decreased birth weight have also been reported in rats following oral exposure to HFPO-DA\n                    <jats:italic>in utero<\/jats:italic>\n                    . Additional exposure-related effects in neonatal rats included hypoglycemia, decreased liver glycogen, and perturbed hepatic expression of genes related to glucose metabolism and peroxisome proliferator activated receptor (PPAR) signaling. A putative rodent-specific adverse outcome pathway (AOP) network was recently developed using these endpoints and assessed for its applicability to PFAS. AOP 1 in this putative AOP network consists of PPAR\u03b1 activation as one of multiple initiating events, with placental insufficiency, neonatal hepatic glycogen deficit, and hypoglycemia as key events leading to neonatal mortality and lower birth weight. To further inform AOP 1 and investigate whether this altered carbohydrate metabolism liver phenotype observed in rat neonates also occurs in HFPO-DA-exposed gravid and non-gravid adult rats, transcriptomic analysis and glycogen staining were performed on archived female rat liver samples from a 15-d developmental and 90-d subchronic toxicity study. HFPO-DA-mediated changes in hepatic gene expression in adult female rats were consistent with PPARa signaling. Changes in hepatic glycogen content and glucose metabolism-related gene expression did not appear to be dependent on HFPO-DA exposure, suggesting that the altered carbohydrate metabolism phenotype observed in neonatal rat livers is not likely to occur in adult female rats, regardless of pregnancy status. Therefore, key events in this AOP for neonatal mortality and lower birthweight are likely limited to the placenta and\/or perinatal rat and are unlikely to be secondary to changes in carbohydrate metabolism in maternal liver. Additionally, findings from this study are consistent with previous mechanistic studies supporting the rodent-specific PPAR\u03b1 mode of action for HFPO-DA-mediated liver effects in rodents.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0345643","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:40:13Z","timestamp":1775065213000},"page":"e0345643","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatic transcriptomic responses in gravid and non-gravid rats exposed to HFPO-DA: Analyses to inform the role of maternal effects in neonatal toxicity"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-617X","authenticated-orcid":true,"given":"Melissa M.","family":"Heintz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie C.","family":"Haws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"9","key":"pone.0345643.ref001","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jat.3812","article-title":"Development of an oral reference dose for the perfluorinated compound GenX","volume":"39","author":"CM Thompson","year":"2019","journal-title":"J Appl Toxicol"},{"key":"pone.0345643.ref002","volume-title":"Human Health Toxicity Values for Hexafluoropropylene Oxide (HFPO) Dimer Acid and Its Ammonium Salt (CASRN 13252\u201313-6 and CASRN 62037\u201380-3) Also Known as \u201cGenX Chemicals\u201d EPA Document Number: 822R-21-010","author":"USEPA","year":"2021"},{"issue":"3","key":"pone.0345643.ref003","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0192623320905803","article-title":"Assessment of the Mode of Action Underlying the Effects of GenX in Mouse Liver and Implications for Assessing Human Health Risks","volume":"48","author":"GA Chappell","year":"2020","journal-title":"Toxicol Pathol"},{"key":"pone.0345643.ref004","doi-asserted-by":"crossref","first-page":"937168","DOI":"10.3389\/ftox.2022.937168","article-title":"Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA","volume":"4","author":"MM Heintz","year":"2022","journal-title":"Front Toxicol"},{"issue":"1","key":"pone.0345643.ref005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/toxsci\/kfad004","article-title":"Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans","volume":"192","author":"MM Heintz","year":"2023","journal-title":"Toxicol Sci"},{"issue":"1","key":"pone.0345643.ref006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/toxsci\/kfae044","article-title":"Comparison of transcriptomic profiles between HFPO-DA and prototypical PPAR\u03b1, PPAR\u03b3, and cytotoxic agents in mouse, rat, and pooled human hepatocytes","volume":"200","author":"MM Heintz","year":"2024","journal-title":"Toxicol Sci"},{"issue":"1","key":"pone.0345643.ref007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/kfae045","article-title":"Comparison of transcriptomic profiles between HFPO-DA and prototypical PPAR\u03b1, PPAR\u03b3, and cytotoxic agents in wild-type and PPAR\u03b1 knockout mouse hepatocytes","volume":"200","author":"MM Heintz","year":"2024","journal-title":"Toxicol Sci"},{"issue":"1","key":"pone.0345643.ref008","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/kfaf049","article-title":"Comparison of phenotypic and transcriptomic profiles between HFPO-DA and prototypical PPAR\u03b1, PPAR\u03b3, and cytotoxic agents in wild-type and Ppara-null mouse livers","volume":"206","author":"MM Heintz","year":"2025","journal-title":"Toxicol Sci"},{"key":"pone.0345643.ref009","doi-asserted-by":"crossref","first-page":"106014","DOI":"10.1016\/j.yrtph.2025.106014","article-title":"Evaluation of chronic toxicity and carcinogenicity of HFPO-DA in mice","volume":"165","author":"CM Thompson","year":"2026","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"pone.0345643.ref010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"JC Corton","year":"2018","journal-title":"Arch Toxicol"},{"key":"pone.0345643.ref011","doi-asserted-by":"crossref","first-page":"104463","DOI":"10.1016\/j.tiv.2019.02.017","article-title":"Identifying qualitative differences in PPAR\u03b1 signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods","volume":"64","author":"PD McMullen","year":"2020","journal-title":"Toxicol In Vitro"},{"key":"pone.0345643.ref012","volume-title":"E.I. du Pont de Nemours and Company. An Oral (Gavage) Reproduction\/Developmental Toxicity Screening Study of H-28548 in Mice. U.S. EPA OPPTS 870.3550; OECD Test Guideline 421. Study conducted by WIL Research Laboratories, LLC (Study Completion Date: December 29, 2010). HERO ID: 4222148","author":"DuPont","year":"2010"},{"key":"pone.0345643.ref013","volume-title":"E.I. du Pont de Nemours and Company. An Oral (Gavage) Prenatal Developmental Toxicity Study of H-28548 in Rats. U.S. EPA OPPTS 870.3700; OECD Test Guideline 414. Study conducted by WIL Research Laboratories, LLC (Study Completion Date: July 2, 2010). HERO ID: 4222145","author":"DuPont","year":"2010"},{"issue":"2","key":"pone.0345643.ref014","doi-asserted-by":"crossref","first-page":"27006","DOI":"10.1289\/EHP6233","article-title":"Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)","volume":"128","author":"BE Blake","year":"2020","journal-title":"Environ Health Perspect"},{"key":"pone.0345643.ref015","doi-asserted-by":"crossref","first-page":"106204","DOI":"10.1016\/j.envint.2020.106204","article-title":"Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat","volume":"146","author":"JM Conley","year":"2021","journal-title":"Environ Int"},{"key":"pone.0345643.ref016","doi-asserted-by":"crossref","first-page":"132536","DOI":"10.1016\/j.jhazmat.2023.132536","article-title":"Association of adverse fetal outcomes with placental inflammation after oral gestational exposure to hexafluoropropylene oxide dimer acid (GenX) in Sprague-Dawley rats","volume":"461","author":"D Lv","year":"2024","journal-title":"J Hazard Mater"},{"issue":"11","key":"pone.0345643.ref017","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/bdr2.2185","article-title":"A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health","volume":"115","author":"JM Rogers","year":"2023","journal-title":"Birth Defects Res"},{"key":"pone.0345643.ref018","volume-title":"E.I. du Pont de Nemours and Company. A 90-day Oral (Gavage) Toxicity Study of H-28548 in Rats with a 28-day Recovery. OECD Test Guideline 408. Study conducted by WIL Research Laboratories, LLC (Study Completion Date: October 5, 2009). HERO ID: 4222142","author":"DuPont","year":"2009"},{"key":"pone.0345643.ref019","author":"FDA","year":"2025"},{"issue":"6","key":"pone.0345643.ref020","doi-asserted-by":"crossref","DOI":"10.2903\/sp.efsa.2022.EN-7341","article-title":"Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment","volume":"19","author":"SE Escher","year":"2022","journal-title":"EFSA Supporting Publications"},{"issue":"5","key":"pone.0345643.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178302","article-title":"A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling","volume":"12","author":"JM Yeakley","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"pone.0345643.ref022","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"8","key":"pone.0345643.ref023","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"S Durinck","year":"2009","journal-title":"Nat Protoc"},{"issue":"8","key":"pone.0345643.ref024","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"L V\u00e4remo","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"pone.0345643.ref025","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/bioinformatics\/bty878","article-title":"BMDExpress 2: enhanced transcriptomic dose-response analysis workflow","volume":"35","author":"JR Phillips","year":"2019","journal-title":"Bioinformatics"},{"key":"pone.0345643.ref026","volume-title":"NTP research report on national toxicology program approach to genomic dose-response modeling. Research report 5 National Toxicology Program","author":"NTP","year":"2018"},{"issue":"3","key":"pone.0345643.ref027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0026-0495(87)90177-6","article-title":"Morphometric study of human hepatic cell modifications induced by fenofibrate","volume":"36","author":"P Gariot","year":"1987","journal-title":"Metabolism"},{"issue":"1","key":"pone.0345643.ref028","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/toxsci\/kft094","article-title":"Temporal concordance between apical and transcriptional points of departure for chemical risk assessment","volume":"134","author":"RS Thomas","year":"2013","journal-title":"Toxicol Sci"},{"issue":"6","key":"pone.0345643.ref029","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/ATVBAHA.118.312282","article-title":"Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats","volume":"39","author":"BJ Wu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"pone.0345643.ref030","article-title":"Pregnancy alters fatty acid metabolism, glucose regulation, and detoxification of the liver in synchrony with biomechanical property changes","volume":"10","author":"J Guo","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"pone.0345643.ref031","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajpath.2019.12.010","article-title":"mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy","volume":"190","author":"M Xu","year":"2020","journal-title":"Am J Pathol"},{"issue":"2","key":"pone.0345643.ref032","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00336.2009","article-title":"The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr","volume":"298","author":"A Milona","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"pone.0345643.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study","volume":"44","author":"JC Corton","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"pone.0345643.ref034","volume-title":"Standard Methods for Development of EPA Transcriptomic Assessment Products (ETAPs). The United States Environmental Protection Agency\u2019s Center for Computational Toxicology and Exposure","author":"A Brennan","year":"2024"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:40:21Z","timestamp":1775065221000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345643"}},"subtitle":[],"editor":[{"given":"Jiafu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345643","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}